| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Original Article |
Departments of Preventive Medicine (M.I.G., K.C., M.L.C.) and Physiology and Biophysics (M.I.G., R.N.B.), Keck School of Medicine, University of Southern California, Los Angeles, California 90033; and Department of Nutrition Sciences (B.A.G.), University of Alabama at Birmingham, Birmingham, Alabama 35294
Address all correspondence and requests for reprints to: Michael I. Goran, Ph.D., Department of Preventive Medicine, University of Southern California, 1540 Alcazar Street, Room 208-D, Los Angeles, California 90033. E-mail: goran{at}usc.edu.
| Abstract |
|---|
|
|
|---|
| Introduction |
|---|
|
|
|---|
Previous studies in adults suggest a strong hereditary component in risk for type 2 diabetes (9, 10, 11, 12, 13, 14, 15, 16, 17). Although these studies have shown an association between family history of type 2 diabetes and insulin resistance in adults, to our knowledge, only two studies have looked at the relationship between family history and insulin resistance in children. One study from 1968 used an oral glucose tolerance test to show greater intolerance to glucose in an ethnically diverse group of obese children with a family history of type 2 diabetes (18), and another study used the insulin-clamp technique in African American children to show a lower insulin-stimulated glucose disposal in those with a positive family history (19). Because of the paucity of information on the influence of family history of type 2 diabetes, the purpose of this study was to examine this issue in more detail in a diverse group of young children. By carefully controlling for the factors already known to influence insulin resistance (i.e. fat mass, puberty, ethnicity), we used a pair-matched design to examine the hypothesis that insulin sensitivity would be lower in children with a positive family history of type 2 diabetes compared with children without a family history of type 2 diabetes.
| Subjects and Methods |
|---|
|
|
|---|
Children were recruited by newspaper and radio advertisements, presentations at local schools, mailings to University and Hospital employees, and by word-of-mouth. No child was taking medications known to affect body composition (e.g. ritalin, GH), was diagnosed with syndromes or diseases known to affect body composition or fat distribution (e.g. Cushingss, Downs, type 1 diabetes), or was diagnosed with any major illness since birth. Ethnicity (Caucasian, African American, or Hispanic) was determined by self-report and was defined by all four grandparents being of the same ethnic group as the child in the study. Two children with a positive family history did not have all four grandparents of the same ethnic group and were included under "other" ethnic group. Children were included who were studied in ongoing studies either in Birmingham, Alabama, or in Los Angeles, California. The data from the study in Alabama were collected between 1997 and 2001, and the data from Los Angeles were collected between 2000 and 2001.
For this analysis, we limited maturation stage to include only children at Tanner stage I or II. Positive family history of type 2 diabetes was evaluated based on medical and family history and was defined by diagnosis of type 2 diabetes in any parent or grandparent of the child in question based on the medical history interview. None of the children were reported to be the products of a diabetic pregnancy. For each child who was identified as having a positive family history of type 2 diabetes, we identified a pair-matched control child from our database in whom measures of insulin sensitivity were available. Pairs of children were matched based on the following criteria: 1) ethnicity; 2) gender; 3) age; 4) Tanner stage; 5) geographical location; and 6) body fat mass. Thus, we created a data set consisting of 21 matched pairs of children (11 males and 10 females) who were very similar in physical and demographic factors, except for presence or absence of a positive family history. The Institutional Review Boards of the University of Southern California and the University of Alabama at Birmingham approved these studies. Both parents provided informed consent, and children signed a child assent form before testing commenced.
Protocol
Children were admitted to the General Clinical Research Center in the late afternoon for an overnight visit. In the afternoon, a detailed medical history and physical examination were performed, including assessment of Tanner stage by a physician based on breast stage and pubic hair development in girls, and genitalia development in boys. The children were served dinner and an evening snack, with all food consumed before 2000 h. Consumption of only water and noncaloric, noncaffeinated beverages was permitted between 2000 h and testing the following morning. The following morning iv lines were placed and an iv glucose tolerance test was performed. Testing was completed by approximately 1200 h.
Tolbutamide-modified, frequently sampled, iv glucose tolerance test
Insulin sensitivity, the acute insulin response to glucose, and the disposition index (product of insulin sensitivity and acute insulin response) were determined using a frequently sampled, iv glucose tolerance test in the early morning after an overnight fast, as reported previously (6). Sera were analyzed in duplicate for glucose using an Ektachem II analyzer (for studies at University of Alabama at Birmingham; Johnson & Johnson Clinical Diagnostics, New Brunswick, NJ) or using a Yellow Springs 2700 Glucose Analyzer (YSI Inc., Yellow Springs, OH) and a glucose oxidase kit (for studies at University of Southern California), and for insulin (RIA; Diagnostic Products, Los Angeles, CA). Values for glucose and insulin were entered into the MINMOD computer program (version 3.0; provided by R.N.B.) for determination of insulin sensitivity, the acute insulin response to glucose, and the disposition index.
Total body fat
Whole body composition (fat mass and fat-free mass) was measured by dual-energy x-ray absorptiometry using a Hologic QDR 4500W densitometer (Hologic, Inc., Bedford, MA) in studies in Los Angeles and a Lunar DPX-L (pediatric software, version 1.5e; Lunar Corp., Madison, WI) in studies in Birmingham.
Data analysis
Variables that were not normally distributed were log transformed before analysis. For ease of interpretation, data are presented in the measured untransformed scale. Parameters of interest were compared in children with a positive family history vs. those without using a t test and a significance level of 0.05. Data analysis was conducted using SPSS version 9.0 (SPSS, Inc., Chicago, IL), and values are presented as means ± SD.
| Results |
|---|
|
|
|---|
|
|
|
|
| Discussion |
|---|
|
|
|---|
The hereditary component of type 2 diabetes and insulin resistance has been studied extensively in adults, with most studies showing greater insulin resistance in offspring of diabetics (9, 10, 11, 12, 13, 15, 16, 17, 19). However, we have only been able to identify two previous studies that have examined the influence of family history of type 2 diabetes on insulin resistance during childhood. In one study from 1968, 66 black, Puerto Rican, and white obese children between 4 and 16 yr of age were studied (18). Fasting glucose and insulin were similar in children with and without a positive family history of diabetes. Because this report published the raw data, we were able to reclassify the children for impaired glucose tolerance based on recent American Diabetes Association guidelines (20). Impaired glucose tolerance (or prediabetes) was evident in 24% of children with a positive family history of diabetes vs. 9% in those without, and the insulin response at 1 h postglucose was almost double in the children with a positive family history (63.6 ± 48.3 vs. 100.3 ± 77 µU/ml; P = 0.03). Although the two groups were matched for percentage over ideal body weight, they were not matched for body fat content, and the group with a positive family history was almost 2.5 yr older (10.9 ± 2.8 vs. 8.5 ± 2.6 yr), raising the possibility of maturational differences in the two groups. In another study with strong outcome measures, 9 prepubertal, healthy African American children with a positive family history of type 2 diabetes were compared with 13 matched children with no family history (19). The groups were matched for age, BMI, degree of adiposity, and physical fitness. There were no differences in fasting glucose and insulin levels, but using the hyperinsulinemic euglycemic clamp technique, the group with a positive family history had lower insulin-stimulated glucose disposal and lower nonoxidative glucose disposal or glucose storage (19).
Taken together with the current study, previous results indicate that, in children, fasting glucose and insulin may not be affected by a positive family history. However, family history may affect the glucose and insulin response to an oral glucose load and insulin sensitivity as assessed by the clamp technique. In contrast, insulin sensitivity when measured by the iv glucose tolerance test may not be affected by a positive family history. The clamp technique may be more sensitive to detecting small differences, and methodological differences may account for some of the discrepant findings. In addition, other factors may need to be considered. One critical factor that may explain these discrepant findings and the difference from what has been observed in adults is age, and more specifically perhaps, maturation stage. Pubertal development is associated with a transient reduction in insulin sensitivity and a compensatory increase in insulin secretion (8). Although no longitudinal studies have tracked changes from mid-puberty to the end of puberty, cross-sectional studies show a recovery of insulin sensitivity by the end of puberty. One possible hypothesis is that the difference in insulin sensitivity due to a positive family history develops during or after puberty. More specifically, there may be a reduced likelihood of full recovery of prepubertal levels of insulin sensitivity in children with a positive family history.
It also could be hypothesized that the influence of a positive family history on insulin resistance during childhood may be different among particularly susceptible subgroups such as the obese or different ethnic groups, so that other studies using careful matching in different states of obesity and among different ethnic groups may be warranted. One limitation of the current study was that we only had limited numbers of matched pairs within each of the obesity groups (6 of the 21 pairs had a 85th BMI-age percentile) and the ethnic groups studied (eight Caucasian pairs, five African American pairs, six Hispanic pairs, and two "other" pairs). Thus, future studies may be warranted to look at the effects of family history of type 2 diabetes within specific ethnic groups. This may be particularly important given the well documented ethnic differences in insulin resistance (5, 6), as well as the likelihood of ethnic differences in the associated compensatory responses to insulin resistance (21).
Several other limitations of this study may be worth considering. First, degree of family history was determined based on an interview and not based on actual measures. For example, some families expressing no family history of type 2 diabetes may, in fact, have familial cases of hidden type 2 diabetes. Future studies should base family history on more objective criteria as assessed, for example, by evaluation of diagnostic tests in family members including an oral glucose tolerance test. Second, many studies have not considered the issue of whether the affected family member is the mother vs. the father, nor the extent of family history with regard to numbers of affected individuals. One previous study showed that the risk of type 2 diabetes was transmitted primarily through an affected parent and increased even more when both the parent and the grandparent had the disease (15). In the current study, we did not evaluate the separate contribution of an affected parent vs. an affected grandparent because our evaluation of family history did not identify who the affected first- or second-degree relative was. It is possible that the potential effect of family history was diluted by inclusion of children with affected grandparents and further studies comparing the effects of first- vs. second-degree family history are needed.
In summary, we used a pair-matched design to identify pairs of prepubertal children who were matched for gender, ethnicity, geographical location, age, and body fat content but differed with regard to reported family history of type 2 diabetes. There were no significant differences in fasting glucose and insulin, insulin sensitivity, acute insulin response to glucose, and the disposition index between children with a positive family history of type 2 diabetes vs. those without a family history. In conclusion, these results support the hypothesis that a positive family history of type 2 diabetes does not have any significant effect on insulin resistance and associated risk factors for type 2 diabetes in young children.
| Acknowledgments |
|---|
| Footnotes |
|---|
Abbreviations: BMI, body mass index.
Received June 12, 2002.
Accepted October 14, 2002.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
L. A. Kelly, C. J. Lane, M. J. Weigensberg, C. Koebnick, C. K. Roberts, J. N. Davis, C. M. Toledo-Corral, G. Q. Shaibi, and M. I. Goran Parental History and Risk of Type 2 Diabetes in Overweight Latino Adolescents: A longitudinal analysis Diabetes Care, October 1, 2007; 30(10): 2700 - 2705. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Valdez, K. J. Greenlund, M. J. Khoury, and P. W. Yoon Is Family History a Useful Tool for Detecting Children at Risk for Diabetes and Cardiovascular Diseases? A Public Health Perspective Pediatrics, September 1, 2007; 120(SUPPLEMENT_2): S78 - S86. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Baptiste-Roberts, T. L. Gary, G. L.A. Beckles, E. W. Gregg, M. Owens, D. Porterfield, and M. M. Engelgau Family History of Diabetes, Awareness of Risk Factors, and Health Behaviors Among African Americans Am J Public Health, May 1, 2007; 97(5): 907 - 912. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. R. Sinaiko, J. Steinberger, A. Moran, C.-P. Hong, R. J. Prineas, and D. R. Jacobs Jr Influence of Insulin Resistance and Body Mass Index at Age 13 on Systolic Blood Pressure, Triglycerides, and High-Density Lipoprotein Cholesterol at Age 19 Hypertension, October 1, 2006; 48(4): 730 - 736. [Abstract] [Full Text] [PDF] |
||||
![]() |
M A Sabin, A L Ford, J M P Holly, L P Hunt, E C Crowne, and J P H Shield Characterisation of morbidity in a UK, hospital based, obesity clinic Arch. Dis. Child., February 1, 2006; 91(2): 126 - 130. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Arslanian, F. Bacha, R. Saad, and N. Gungor Family History of Type 2 Diabetes Is Associated With Decreased Insulin Sensitivity and an Impaired Balance Between Insulin Sensitivity and Insulin Secretion in White Youth Diabetes Care, January 1, 2005; 28(1): 115 - 119. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Jago, T. Baranowski, K. Watson, J. C. Baranowski, T. Nicklas, and I. F. Zakeri Relationships Between Maternal and Child Cardiovascular Risk Factors: Ethnic Differences and Lack of Influence of Physical Activity Arch Pediatr Adolesc Med, December 1, 2004; 158(12): 1125 - 1131. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Rosenbaum, C. Nonas, M. Horlick, I. Fennoy, I. Vargas, H. Schachner, P. Kringas, K. Stanton, R. Weil, and and the El Camino Diabetes Prevention Group {beta}-Cell Function and Insulin Sensitivity in Early Adolescence: Association with Body Fatness and Family History of Type 2 Diabetes Mellitus J. Clin. Endocrinol. Metab., November 1, 2004; 89(11): 5469 - 5476. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. S. Conwell, S. G. Trost, W. J. Brown, and J. A. Batch Indexes of Insulin Resistance and Secretion in Obese Children and Adolescents: A validation study Diabetes Care, February 1, 2004; 27(2): 314 - 319. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |